Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)

Tristetraprolin Regulates CXCL1 (KC) mRNA Stability

(2014) S. Datta et al.   JOURNAL OF IMMUNOLOGY

IL-17 Signaling for mRNA Stabilization Does Not Require TNF Receptor-Associated Factor 6

(2014) J. Hartupee et al.   JOURNAL OF IMMUNOLOGY

Diversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression

(2010) Thomas Hamilton et al.   CYTOKINE

The splicing factor ASF/SF2 is associated with TIA-1-related/TIA-1-containing ribonucleoproteic complexes and contributes to post-transcriptional repression of gene expression

(2010) Nathalie Delestienne et al.   FEBS Journal

Astrocyte-Restricted Ablation of Interleukin-17-Induced Act1-Mediated Signaling Ameliorates Autoimmune Encephalomyelitis

(2010) Zizhen Kang et al.   IMMUNITY

IL-17 and Th17 Cells

(2009) Thomas Korn et al.   Annual Review of Immunology

Structural Basis for the Lack of E2 Interaction in the RING Domain of TRAF2

(2009) Qian Yin et al.   BIOCHEMISTRY

IL-17 Regulates CXCL1 mRNA Stability via an AUUUA/Tristetraprolin-Independent Sequence

(2009) S. Datta et al.   JOURNAL OF IMMUNOLOGY

Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling

(2009) C. Liu et al.   Science Signaling

The SR protein family of splicing factors: master regulators of gene expression

(2008) Jennifer C. Long et al.   BIOCHEMICAL JOURNAL

The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation

(2008) Wenjun Ouyang et al.   IMMUNITY

Efficiency of the Pioneer Round of Translation Affects the Cellular Site of Nonsense-Mediated mRNA Decay

(2008) Hanae Sato et al.   MOLECULAR CELL

Post-transcriptional control of cytokine production

(2008) Paul Anderson   NATURE IMMUNOLOGY